Skip to main content
Testing version — LOERadar is in active testing. Features and data may change.
LOERadar
LOE
Radar
Hub
News
Changes
Search
Log in
Get Started
TRYVIO (APROCITENTAN) | LOERadar
Viewing data from:
Latest
2026-07-01
2026-06-01
2026-05-01
2026-04-01
2026-03-28
2026-02-17
2026-02-10
2025-12-14
2025-02-26
2025-01-25
2024-11-08
2023-07-23
2023-06-15
2023-05-13
2023-01-26
2022-11-22
2022-10-28
2022-09-29
2022-07-09
2022-06-29
2022-04-08
2022-03-09
2021-12-28
2021-05-05
2021-03-12
2020-12-22
2020-11-12
2019-12-14
2019-09-15
TRYVIO
NDA
Get alerts
APROCITENTAN | N217686 | IDORSIA PHARMACEUTICALS LTD
1 strength
6 unique patents
1 unique exclusivity
Patents
SEC Intel
Revenue
PTAB
Reexams
Litigation
Petitions
Trials
Approvals
Label
Products
Patent Timeline
6 unique patents, 1 exclusivity by expiration date
Active (6)
Today
Exclusivity
2026
2027
2028
2029
2030
2031
2032
2033
2034
2035
2036
2037
2038
2039
Today
8324232
Sep. 21, 2029
10919881
Feb. 26, 2038
11174247
Nov. 6, 2037
11680058
Jul. 26, 2038
11787782
Mar. 2, 2038
12297189
Feb. 26, 2038
NCE
Mar. 22, 2029
PTAB Proceedings
No IPR/PGR/CBM challenges found at the Patent Trial and Appeal Board
Hatch-Waxman Litigation
No ANDA patent litigation cases (NOS 835) matched from PACER
Citizen Petitions
No FDA citizen petitions matched from Regulations.gov
Products (1)
#001 — 12.5MG
RLD
6 patents
1 exclusivity
▴
TABLET;ORAL | Approved: Mar 19, 2024
Patents (6)
Patent #
Expiration
PED
Drug Substance
Drug Product
Use Code
Delist
8324232
Sep 21, 2029
—
Yes
Yes
U-3878
TREATMENT OF HYPERTENSION IN COMBINATION WITH OTHER ANTIHYPERTENSIVE DRUGS, TO LOWER BLOOD PRESSURE IN ADULT PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED ON OTHER DRUGS
—
10919881
Feb 26, 2038
—
Yes
Yes
—
—
11174247
Nov 6, 2037
—
—
—
U-3879
TREATMENT OF HYPERTENSION IN COMBINATION WITH OTHER ANTIHYPERTENSIVE DRUGS, INCLUDING AN ANGIOTENSIN RECEPTOR BLOCKER, TO LOWER BLOOD PRESSURE IN ADULT PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED ON OTHER DRUGS
—
11680058
Jul 26, 2038
—
—
—
U-3878
TREATMENT OF HYPERTENSION IN COMBINATION WITH OTHER ANTIHYPERTENSIVE DRUGS, TO LOWER BLOOD PRESSURE IN ADULT PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED ON OTHER DRUGS
—
11787782
Mar 2, 2038
—
—
—
U-3877
TREATMENT OF HYPERTENSION IN COMBINATION WITH OTHER ANTIHYPERTENSIVE DRUGS, INCLUDING AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR, TO LOWER BLOOD PRESSURE IN ADULT PATIENTS WHO ARE NOT ADEQUATELY CONTROLLED ON OTHER DRUGS
—
12297189
Feb 26, 2038
—
—
Yes
—
—
Exclusivities (1)
Code
Date
Status
NCE
Mar 22, 2029
Active